Castlight Health, Inc. Conference Call to Review First Quarter 2014 Results Scheduled for May 7 at 2pm PT

Apr 15, 2014

SAN FRANCISCO – April 14, 2014 – Castlight Health, Inc. (NYSE: CSLT), a leading provider of enterprise healthcare cloud software, today announced that it has scheduled a conference call to review its first quarter 2014  results (ended March 31, 2014) for Wednesday, May 7, 2014 at 2:00 pm  Pacific Time (5:00 pm Eastern Time).

To listen to the conference call live, dial 1-877-407-0789. Please dial in at least five minutes before the scheduled start time.  A live webcast can be accessed at

A replay of the call will be available, beginning at approximately 5:00 pm Pacific Time on May 7, 2014 for two days, at 1-877-870-5176, and archived via webcast at  The replay access code is 13580401.

A press release highlighting the company’s results will be issued in advance of the conference call and will be accessible at in the Investor Relations section.

About Castlight Health

Castlight Health (NYSE: CSLT) is a pioneer of the Enterprise Healthcare Cloud and a leading provider of cloud-based software for healthcare. Founded in 2008, San Francisco-based Castlight makes healthcare data actionable, empowering our enterprise customers to gain control over their healthcare spending and transforming how companies and employees engage in healthcare. With Castlight, employers can implement technology-enabled benefit designs, integrate disparate healthcare applications, and provide meaningful information to employees and their families. More than 100 companies, ranging from medium-sized businesses to Fortune 50 enterprises, have selected Castlight. For more information visit Follow us on Twitter and LinkedIn and Like us on Facebook. Source: Castlight Health


Media Contact:

Lorie Fiber

l[email protected]


Investor Contact:

Kristin Baker Spohn

[email protected]


Copyright 2014 Castlight Health, Inc. Castlight Health® is the registered trademark of Castlight Health Inc. Other company and product names may be trademarks of the respective companies with which they are associated.

Press Information

[email protected]